Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers

NANot yet recruitingINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 29, 2029

Study Completion Date

September 29, 2029

Conditions
GlaucomaOcular Hypertension
Interventions
OTHER

Glaucoma screening using an AI-algorithm and screening for diabetic retinopathy, cataract, and visual acuity impairment.

Participants who have the glaucoma screening will undergo an Artificial Intelligence Remote Optic Nerve Assessment (AI-RONA). The AI information may or may not be used by the FQHC provider to refer their patient for follow-up eye exam. It is information that the provider may find useful in making a referral.

Trial Locations (1)

35294-0009

Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

University of California, San Diego

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT06629649 - Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers | Biotech Hunter | Biotech Hunter